ALNYLAM PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 777567000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/83c0bd14-59de-4602-9a52-a5028be166b8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-26-007497Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/accounts-receivable/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/83c0bd14-59de-4602-9a52-a5028be166b8
History
- no predecessors — first report